With the advent of all oral direct-acting antiviral drugs (DAAs) with a low incidence of side effects and very high success rates, we are entering an exciting new era in the treatment of hepatitis C virus (HCV), and now the major goal is the elimination of this viral infection. However, at least in Latin America, there are multiple barriers that must be attended.
CITATION STYLE
Kershenobich, D., & Flores, N. (2020). Challenges and Strategies for Access to Treatment of Hepatitis C in Latin America. In Hepatitis B and C. IntechOpen. https://doi.org/10.5772/intechopen.83557
Mendeley helps you to discover research relevant for your work.